Tailored bioanalytical services for preclinical to clinical studies, primarily for biologics/large molecules, biosimilars, peptides, and gene therapy products
You want more than a vendor; you need a partner who acts as an extension of your internal team, with strong communication and a shared vision for success.
Our clients consistently tell us they trust our scientists to think like drug developers, not just data generators.
This video is unavailable. You have to activate analytics category cookies in Cookie Settings and refresh the page to be able to view this content.
Actionable data
Have you ever questioned your data? We provide actionable data you can trust directly and act on with confidence.
Product Mindset
Our unique heritage as a developer and manufacturer of gold-standard immunoassays gives us an unparalleled “product mindset.”
Together with our clients, we evaluate the project needs and feasibility.
Exchange of detailed project information is ensured to facilitate a comprehensive understanding of the project.
At Mercodia, we recognize the critical importance of involving the right competences from the early stages to ensure the success of the project.
The initiation of the project is marked by the signing of the quote. Subsequently, a dedicated team comprising project managers, scientists, study analysts, production managers, and other relevant personnel is promptly assigned to the project.
During this phase, the execution/analytical plan is designed, agreed upon, and formally signed.
Additionally, relevant activities such as risk assessment and the formulation of risk mitigation plans, data transfer agreements, and/or detailed specifications are elaborated.
Throughout the execution phase, adherence to the execution/analytical plan is maintained. Milestones and activities aimed at mitigating risks are undertaken, with simultaneous updates on project status, deliverable transfers, and adherence to predetermined Stop&Go decisions.
The project finalization phase involves the delivery and acceptance of results, along with the handover of the project report if previously agreed upon. Subsequently, a comprehensive project review is conducted, providing feedback on the services rendered.
This phase also includes discussions about potential follow-up projects and future collaborations.
Unmatched cardiometabolic focus
Our skilled team provides unmatched scientific depth and understanding of the specific biomarkers and challenges in diabetes, obesity, and related cardiorenal-metabolic conditions. This expertise is built on over 30 years of developing and commercializing our own portfolio of gold-standard cardiometabolic ELISAs.
We have led over 200 cardiometabolic bioanalytical studies and analyzed hundreds of thousands of samples. This real-world experience allows us to troubleshoot complex assays and matrices, and design a successful bioanalytical strategy for all stages of preclinical and clinical development.
Annika Carlsson Director Bioanalytical Services